Drug intelligence / Profile preview

[99mTc]Tc-EDDA-HTK03180

Development stage
Preclinical
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

[99mTc]Tc-EDDA-HTK03180 is an investigational **PSMA-targeted radiopharmaceutical imaging agent** for prostate cancer SPECT imaging. It is a **technetium-99m labeled small-molecule tracer** built on a lysine-ureido-α-aminoadipic acid pharmacophore and incorporates a HYNIC chelator with tranexamic acid and 9-anthrylalanine; EDDA is used as a co-ligand for technetium coordination. The tracer is designed to bind **prostate-specific membrane antigen** on prostate cancer cells and enable lesion visualization by SPECT/CT. Based on the provided preclinical literature context, it has shown tumor uptake in PSMA-expressing LNCaP xenografts with lower spleen and salivary gland uptake than comparator PSMA SPECT tracers, and it remains in **preclinical research-stage development**.

Other names
technetium Tc 99m EDDA-HTK03180
02

Targets

PSMA (Prostate-specific membrane antigen)

Beyond the preview

Go deeper on [99mTc]Tc-EDDA-HTK03180.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on [99mTc]Tc-EDDA-HTK03180.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call